Maiken Bang Hansen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maiken Bang Hansen has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Mogens Groenvold
Palliative Care Research Unit, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark; Department of Public Health, University of Copenhagen, Denmark
15 shared publications - Leslye Rojas-Concha
Palliative Care Research Unit, Department of Geriatrics and Palliative Medicine GP, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark
11 shared publications - Mathilde Adsersen
Palliative Care Research Unit, Department of Geriatric and Palliative Medicine GP, Bispebjerg and Frederiksberg Hospitals, University of Copenhagen, Denmark
10 shared publications Morten Aagaard Petersen
Palliative Care Research Unit, Department of Geriatrics and Palliative Medicine GP, Bispebjerg and Frederiksberg Hospital, Denmark
7 shared publicationsMogens Groenvold
Copenhagen University Hospital – Bispebjerg and Frederiksberg, University of Copenhagen
5 shared publications- Morten Aagaard Petersen
Department of Geriatrics and Palliative Medicine GP, Bispebjerg and Frederiksberg Hospital, University of Copenhagen, Copenhagen, Denmark
5 shared publications
Latest Publications
- Open Access
- 28 April 2026
- Published by Elsevier in European Journal of Oncology Nursing
- Vol. 82, 103199
What ‘capitals’ are needed to enable assessment of palliative care needs in home care? A qualitative interview study with home care nurses
- 28 April 2026
- Published by Elsevier in European Journal of Oncology Nursing
- Vol. 82, 103199
Open AccessWhat ‘capitals’ are needed to enable assessment of palliative care needs in home care? A qualitative interview study with home care nurses
- 26 February 2026
- Published by SAGE Publications in Journal of Palliative Care
A National Survey of Health Care Professionals’ Use and Perception of Patient-Reported Outcomes (EORTC QLQ-C15-PAL) in the Patient Trajectory in Specialized Palliative Care
Objective: Patient-reported outcome measures (PROMs) and their integration into clinical practice are important topics in health care. However, little is known about health care professionals’ (HCPs) perception and use of PROMs. We therefore investigated the use of PROMs by HCPs in specialized palliative care (SPC) and how PROM data are perceived by these HCPs. Method: A survey was sent to the heads of SPC services in Denmark (N = 41), asking them to distribute the survey to their HCPs with patient contact. Results: The survey (N = 160) showed that 75% of the HCPs reported that they looked at PROM responses from at least 75% of the patients in whom PROMs had been performed prior to the first consultation, whereas the proportion of HCPs looking at PROM responses was lower for subsequent contacts (45%-51%). Sixty percent of the HCPs reported that they used PROMs in the first consultation, and around 40% compared a completed PROM from the first consultation with PROMs done in later consultations. Many HCPs experienced that PROMs gave them knowledge about the patient's situation (89%), was meaningful (86%), and that they understood how and why PROMs were used (92%). According to most HCPs, patients understood why they completed a PROM (84%), and patients found the completion meaningful (70%). Few differences between health professions were found. Conclusions: In Denmark, PROMs are often part of the first SPC consultation and generally used in dialogue with the patient. However, increased integration of PROMs is needed later in the palliative trajectory.
- 26 February 2026
- Published by SAGE Publications in Journal of Palliative Care
A National Survey of Health Care Professionals’ Use and Perception of Patient-Reported Outcomes (EORTC QLQ-C15-PAL) in the Patient Trajectory in Specialized Palliative Care
Objective: Patient-reported outcome measures (PROMs) and their integration into clinical practice are important topics in health care. However, little is known about health care professionals’ (HCPs) perception and use of PROMs. We therefore investigated the use of PROMs by HCPs in specialized palliative care (SPC) and how PROM data are perceived by these HCPs. Method: A survey was sent to the heads of SPC services in Denmark (N = 41), asking them to distribute the survey to their HCPs with patient contact. Results: The survey (N = 160) showed that 75% of the HCPs reported that they looked at PROM responses from at least 75% of the patients in whom PROMs had been performed prior to the first consultation, whereas the proportion of HCPs looking at PROM responses was lower for subsequent contacts (45%-51%). Sixty percent of the HCPs reported that they used PROMs in the first consultation, and around 40% compared a completed PROM from the first consultation with PROMs done in later consultations. Many HCPs experienced that PROMs gave them knowledge about the patient's situation (89%), was meaningful (86%), and that they understood how and why PROMs were used (92%). According to most HCPs, patients understood why they completed a PROM (84%), and patients found the completion meaningful (70%). Few differences between health professions were found. Conclusions: In Denmark, PROMs are often part of the first SPC consultation and generally used in dialogue with the patient. However, increased integration of PROMs is needed later in the palliative trajectory.
- Open Access
- 10 December 2025
- Published by Springer Nature in BMC Palliative Care
- Vol. 25 (1)
Effect of implementing clinical guidelines for treatment of symptoms in advanced cancer patients in specialist palliative care: a nationwide register-based study
There is limited evidence on whether the implementation of clinical guidelines has a positive effect on the symptomatology of cancer patients in palliative
- 10 December 2025
- Published by Springer Nature in BMC Palliative Care
- Vol. 25 (1)
Open AccessEffect of implementing clinical guidelines for treatment of symptoms in advanced cancer patients in specialist palliative care: a nationwide register-based study
There is limited evidence on whether the implementation of clinical guidelines has a positive effect on the symptomatology of cancer patients in palliative
- Open Access
- 5 November 2025
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 33 (12) , 1-13
Differences in symptoms and problems experienced by patients with a life-threatening disease in specialized palliative care and basic palliative care—a nationwide cross-sectional study
Background: Patients with a life-threatening disease often experience palliative care needs (symptoms and problems) before death, and those with the most complex needs should be those who get access to specialized palliative care. To examine if that is the case, studies are needed comparing palliative care needs of patients with life-threatening cancer and non-cancer diseases admitted to specialized palliative care to patients receiving basic palliative care. Aims: To compare palliative care needs among patients with a life-threatening disease admitted to specialized palliative care and patients receiving basic palliative care. Design: A secondary data analysis of symptoms/problems reported by patients in basic palliative care or at admittance to specialized palliative care in Denmark. Ordinal logistic regression was performed to study differences in the probability of experiencing each symptom/problem among patients receiving specialized palliative care vs. basic palliative care, controlled for possible confounders. Setting/participants: Patients with a life-threatening disease who completed the EORTC QLQ-C15-PAL questionnaire. Results: The study included 6367 patients. The odds of experiencing symptoms, impaired physical functioning, impaired emotional functioning, and poor quality of life were higher at admittance to specialized palliative care compared to an ongoing basic palliative care, especially impaired physical functioning (OR 8.3, 95% CI 6.6–10.5) and fatigue (OR 5.1, 95% CI 4.1–6.5). Conclusions: Patients in specialized palliative care had higher levels of symptoms and problems than patients with a life-threatening disease receiving basic palliative care, especially non-cancer patients. Future research should study changes in symptoms/problems during the disease trajectory among patients with life-threatening diseases to improve referrals to specialized palliative care.
- 5 November 2025
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 33 (12) , 1-13
Open AccessDifferences in symptoms and problems experienced by patients with a life-threatening disease in specialized palliative care and basic palliative care—a nationwide cross-sectional study
Background: Patients with a life-threatening disease often experience palliative care needs (symptoms and problems) before death, and those with the most complex needs should be those who get access to specialized palliative care. To examine if that is the case, studies are needed comparing palliative care needs of patients with life-threatening cancer and non-cancer diseases admitted to specialized palliative care to patients receiving basic palliative care. Aims: To compare palliative care needs among patients with a life-threatening disease admitted to specialized palliative care and patients receiving basic palliative care. Design: A secondary data analysis of symptoms/problems reported by patients in basic palliative care or at admittance to specialized palliative care in Denmark. Ordinal logistic regression was performed to study differences in the probability of experiencing each symptom/problem among patients receiving specialized palliative care vs. basic palliative care, controlled for possible confounders. Setting/participants: Patients with a life-threatening disease who completed the EORTC QLQ-C15-PAL questionnaire. Results: The study included 6367 patients. The odds of experiencing symptoms, impaired physical functioning, impaired emotional functioning, and poor quality of life were higher at admittance to specialized palliative care compared to an ongoing basic palliative care, especially impaired physical functioning (OR 8.3, 95% CI 6.6–10.5) and fatigue (OR 5.1, 95% CI 4.1–6.5). Conclusions: Patients in specialized palliative care had higher levels of symptoms and problems than patients with a life-threatening disease receiving basic palliative care, especially non-cancer patients. Future research should study changes in symptoms/problems during the disease trajectory among patients with life-threatening diseases to improve referrals to specialized palliative care.
- Open Access
- 2 August 2025
- Published by Taylor & Francis in Progress in Palliative Care
- Vol. 33 (4) , 155-165
Comparing patient reported palliative symptoms and problems among kidney, heart, lung and cancer patients – An initial investigation
- 2 August 2025
- Published by Taylor & Francis in Progress in Palliative Care
- Vol. 33 (4) , 155-165
Open AccessComparing patient reported palliative symptoms and problems among kidney, heart, lung and cancer patients – An initial investigation
- Open Access
- 14 June 2025
- Published by Springer Nature in Quality of Life Research
- Vol. 34 (9) , 2651-2662
Patients’ experiences of responding to a Patient-Reported Outcome Measure for palliative care: a mixed method study
Background: Worldwide, there is growing interest in using Patient-Reported Outcome Measures (PROM) in palliative care. The Danish Health Data Authority has developed a new PROM called PRO-Pall, which was launched for nationwide use in patients with heart, lung, and kidney diseases, as well as cancer. Aim: To explore patients’ experiences of responding to the PRO-Pall and using it in a consultation about palliative care needs in non-specialised palliative care settings. Methods: This is a multicentre, mixed-methods study combining a quantitative approach using structured questionnaires (n = 270) and a qualitative analysis based on semi-structured interviews (n = 17). The quantitative survey included items assessing relevance, ease of use, and perceived benefits of PRO-Pall in preparing for consultations. Qualitative data collection involved interviews focusing on patients’ experiences with PRO-Pall and its integration into clinical discussions. Quantitative data were analysed descriptively as numbers (n) and proportions (%), while qualitative data were analysed using thematically using to identify key themes. Results: A total of 270 patients completed the survey, and 17 patients participated in interviews. The analysis revealed that the patients evaluated the PRO-Pall positively. The patients strongly agreed or agreed that the PRO-Pall was relevant (85%), easy to fill out (85%), helped to become aware of symptoms (61%) and a good way to prepare for the consultation (70%). The qualitative findings further supported these results, highlighting that patients found PRO-Pall relevant, appropriate, and convenient. Participants emphasized that PRO-Pall responses should be actively discussed during consultations with healthcare professionals to enhance its impact. Additionally, they noted that the timing of completing PRO-Pall was crucial, as patients’ conditions fluctuate over time, potentially influencing their responses. Conclusion: Most patients found the PRO-Pall relevant, appropriate, and easy to fill out. However, its effectiveness depends on healthcare professionals actively integrating patient responses into consultations. Otherwise, it would serve merely as documentation rather than an avenue for patients to discuss their concerns.
- 14 June 2025
- Published by Springer Nature in Quality of Life Research
- Vol. 34 (9) , 2651-2662
Open AccessPatients’ experiences of responding to a Patient-Reported Outcome Measure for palliative care: a mixed method study
Background: Worldwide, there is growing interest in using Patient-Reported Outcome Measures (PROM) in palliative care. The Danish Health Data Authority has developed a new PROM called PRO-Pall, which was launched for nationwide use in patients with heart, lung, and kidney diseases, as well as cancer. Aim: To explore patients’ experiences of responding to the PRO-Pall and using it in a consultation about palliative care needs in non-specialised palliative care settings. Methods: This is a multicentre, mixed-methods study combining a quantitative approach using structured questionnaires (n = 270) and a qualitative analysis based on semi-structured interviews (n = 17). The quantitative survey included items assessing relevance, ease of use, and perceived benefits of PRO-Pall in preparing for consultations. Qualitative data collection involved interviews focusing on patients’ experiences with PRO-Pall and its integration into clinical discussions. Quantitative data were analysed descriptively as numbers (n) and proportions (%), while qualitative data were analysed using thematically using to identify key themes. Results: A total of 270 patients completed the survey, and 17 patients participated in interviews. The analysis revealed that the patients evaluated the PRO-Pall positively. The patients strongly agreed or agreed that the PRO-Pall was relevant (85%), easy to fill out (85%), helped to become aware of symptoms (61%) and a good way to prepare for the consultation (70%). The qualitative findings further supported these results, highlighting that patients found PRO-Pall relevant, appropriate, and convenient. Participants emphasized that PRO-Pall responses should be actively discussed during consultations with healthcare professionals to enhance its impact. Additionally, they noted that the timing of completing PRO-Pall was crucial, as patients’ conditions fluctuate over time, potentially influencing their responses. Conclusion: Most patients found the PRO-Pall relevant, appropriate, and easy to fill out. However, its effectiveness depends on healthcare professionals actively integrating patient responses into consultations. Otherwise, it would serve merely as documentation rather than an avenue for patients to discuss their concerns.
- 28 August 2024
- Published by SAGE Publications in Palliative Medicine
- Vol. 38 (9) , 1021-1032
Differences in palliative care needs between cancer patients and non-cancer patients at the start of specialized palliative care: A nationwide register-based study
Background: Patients with non-cancer disease are less likely to receive specialized palliative care than cancer patients. To be able to provide the best specialized palliative care, it is important to understand palliative care needs of non-cancer patients and whether the type and level of needs differ from those of cancer patients. Large studies including both cancer and non-cancer patients, using validated needs-assessment-tools, are needed to understand differences in palliative care needs at admittance to specialized palliative care. Aims: To compare palliative care needs at the start of palliative care for cancer and non-cancer disease. Design: Six-year nationwide register-based study. Setting/participants: This study included patients from all Danish specialized palliative care services (hospice care, hospital-based palliative care, home-based palliative care, or consultation) who completed a need-assessment-questionnaire. Ordinal logistic regression was performed to study the association between diagnosis and needs. Results: Cancer patients had a higher probability of receiving specialized palliative care. Of the 44,315 palliative care admissions included in this study, 93.3% were on cancer patients. Independent of diagnosis patients experienced on average six needs and high levels of fatigue and impaired physical functioning. Non-cancer patients had significantly higher odds of insomnia, fatigue and impaired emotional functioning, physical functioning, and quality of life whereas cancer patients had higher odds of pain (except for patients with neurological disease). Conclusions: The higher levels of several symptoms/problems among non-cancer patients compared to cancer patients suggests that referral to specialized palliative care should be improved for non-cancer patients perhaps by improving identification of palliative needs.
- 28 August 2024
- Published by SAGE Publications in Palliative Medicine
- Vol. 38 (9) , 1021-1032
Differences in palliative care needs between cancer patients and non-cancer patients at the start of specialized palliative care: A nationwide register-based study
Background: Patients with non-cancer disease are less likely to receive specialized palliative care than cancer patients. To be able to provide the best specialized palliative care, it is important to understand palliative care needs of non-cancer patients and whether the type and level of needs differ from those of cancer patients. Large studies including both cancer and non-cancer patients, using validated needs-assessment-tools, are needed to understand differences in palliative care needs at admittance to specialized palliative care. Aims: To compare palliative care needs at the start of palliative care for cancer and non-cancer disease. Design: Six-year nationwide register-based study. Setting/participants: This study included patients from all Danish specialized palliative care services (hospice care, hospital-based palliative care, home-based palliative care, or consultation) who completed a need-assessment-questionnaire. Ordinal logistic regression was performed to study the association between diagnosis and needs. Results: Cancer patients had a higher probability of receiving specialized palliative care. Of the 44,315 palliative care admissions included in this study, 93.3% were on cancer patients. Independent of diagnosis patients experienced on average six needs and high levels of fatigue and impaired physical functioning. Non-cancer patients had significantly higher odds of insomnia, fatigue and impaired emotional functioning, physical functioning, and quality of life whereas cancer patients had higher odds of pain (except for patients with neurological disease). Conclusions: The higher levels of several symptoms/problems among non-cancer patients compared to cancer patients suggests that referral to specialized palliative care should be improved for non-cancer patients perhaps by improving identification of palliative needs.
- Open Access
- 2 May 2024
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 63 (1) , 259-266
The first decade of the Danish Palliative Care Database: improvements and ongoing challenges in the quality and use of specialised palliative care
Background: Danish Palliative Care Database comprises five quality indicators: (1) Contact with specialised palliative care (SPC) among referred patients, (2) Waiting time of less than 10 days, (3) Proportion of patients who died from (A) cancer or (B) non-cancer diseases, and had contact with SPC, (4) Proportion of patients completing the patient-reported outcome measure at baseline (EORTC QLQ-C15-PAL), and (5) Proportion of patients discussed at a multidisciplinary conference. Purpose: To investigate changes in the quality indicators from 2010 until 2020 in cancer and non-cancer patients. Patients/material: Patients aged 18+ years who died from 2010 until 2020. Method: Register-based study with the Danish Palliative Care Database as the main data source. Indicator changes were reported as percentage fulfilment. Results: From 2010 until 2020, the proportion of patients with non-cancer diseases in SPC increased slightly (2.5–7.2%). In 2019, fulfilment of the five indicators for cancer and non-cancer were: (1) 81% vs. 73%; (2) 73% vs. 68%; (3A) 50%; (3B) 2%; (4) 73% vs. 66%; (5) 73% vs. 65%. Whereas all other indicators improved, the proportion of patients waiting less than 10 days from referral to contact decreased. Differences between type of unit were found, mainly lower for hospice. Interpretation: Most patients in SPC had cancer. All indicators except waiting time improved during the 10-year period. The establishment of the Danish Palliative Care Database may have contributed to the positive development; however, SPC in Denmark needs to be improved, especially regarding a reduction in waiting time and enhanced contact for non-cancer patients.
- 2 May 2024
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 63 (1) , 259-266
Open AccessThe first decade of the Danish Palliative Care Database: improvements and ongoing challenges in the quality and use of specialised palliative care
Background: Danish Palliative Care Database comprises five quality indicators: (1) Contact with specialised palliative care (SPC) among referred patients, (2) Waiting time of less than 10 days, (3) Proportion of patients who died from (A) cancer or (B) non-cancer diseases, and had contact with SPC, (4) Proportion of patients completing the patient-reported outcome measure at baseline (EORTC QLQ-C15-PAL), and (5) Proportion of patients discussed at a multidisciplinary conference. Purpose: To investigate changes in the quality indicators from 2010 until 2020 in cancer and non-cancer patients. Patients/material: Patients aged 18+ years who died from 2010 until 2020. Method: Register-based study with the Danish Palliative Care Database as the main data source. Indicator changes were reported as percentage fulfilment. Results: From 2010 until 2020, the proportion of patients with non-cancer diseases in SPC increased slightly (2.5–7.2%). In 2019, fulfilment of the five indicators for cancer and non-cancer were: (1) 81% vs. 73%; (2) 73% vs. 68%; (3A) 50%; (3B) 2%; (4) 73% vs. 66%; (5) 73% vs. 65%. Whereas all other indicators improved, the proportion of patients waiting less than 10 days from referral to contact decreased. Differences between type of unit were found, mainly lower for hospice. Interpretation: Most patients in SPC had cancer. All indicators except waiting time improved during the 10-year period. The establishment of the Danish Palliative Care Database may have contributed to the positive development; however, SPC in Denmark needs to be improved, especially regarding a reduction in waiting time and enhanced contact for non-cancer patients.
- Open Access
- 2 February 2024
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 32 (2) , 1-11
Symptoms and problems reported by patients with non-cancer diseases through open-ended questions in specialist palliative care: a national register-based study
Purpose: Since 2010, a comprehensive symptom/problem (S/P) assessment has been carried out in Danish specialist palliative care using the EORTC QLQ-C15-PAL questionnaire and the open-ended “Write In three Symptoms/Problems” (WISP) instrument. On WISP patients can report up to three S/Ps not included in the EORTC QLQ-C15-PAL. However, little is known about which S/Ps patients with non-cancer diseases report using WISP. Therefore, we investigated the prevalence and severity of S/Ps reported on WISP by non-cancer patients in specialist palliative care and compared these S/Ps with those previously reported by cancer patients. Methods: This register-based study collected data from the Danish Palliative Care Database. We included adult patients with non-cancer diseases answering the EORTC QLQ-C15-PAL at admittance to specialist palliative care between 2016 and 2021. WISP responses were qualitatively categorized, and their prevalence and severity calculated. Results: Of the 2323 patients with non-cancer diseases answering the EORTC QLQ-C15-PAL, 812 (34.9%) reported at least one S/P using WISP. A total of 1340 S/Ps were reported on WISP, of which 56.7% were not included in the EORTC QLQ-C15-PAL (i.e., were new). Edema, existential problems, dizziness, cough, and dysphagia were the most prevalent new S/Ps. Overall, 88.7% of the S/Ps were scored as moderate-severe. The prevalence of S/Ps reported on WISP did not significantly differ between cancer and non-cancer patients, except for existential problems, dysphagia, myoclonus, speaking problems, sweats, and vomiting. Conclusion: The similarities and differences in the prevalence of the most common S/Ps reported on WISP confirm that WISP improves symptom assessment regardless of patient diagnosis.
- 2 February 2024
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 32 (2) , 1-11
Open AccessSymptoms and problems reported by patients with non-cancer diseases through open-ended questions in specialist palliative care: a national register-based study
Purpose: Since 2010, a comprehensive symptom/problem (S/P) assessment has been carried out in Danish specialist palliative care using the EORTC QLQ-C15-PAL questionnaire and the open-ended “Write In three Symptoms/Problems” (WISP) instrument. On WISP patients can report up to three S/Ps not included in the EORTC QLQ-C15-PAL. However, little is known about which S/Ps patients with non-cancer diseases report using WISP. Therefore, we investigated the prevalence and severity of S/Ps reported on WISP by non-cancer patients in specialist palliative care and compared these S/Ps with those previously reported by cancer patients. Methods: This register-based study collected data from the Danish Palliative Care Database. We included adult patients with non-cancer diseases answering the EORTC QLQ-C15-PAL at admittance to specialist palliative care between 2016 and 2021. WISP responses were qualitatively categorized, and their prevalence and severity calculated. Results: Of the 2323 patients with non-cancer diseases answering the EORTC QLQ-C15-PAL, 812 (34.9%) reported at least one S/P using WISP. A total of 1340 S/Ps were reported on WISP, of which 56.7% were not included in the EORTC QLQ-C15-PAL (i.e., were new). Edema, existential problems, dizziness, cough, and dysphagia were the most prevalent new S/Ps. Overall, 88.7% of the S/Ps were scored as moderate-severe. The prevalence of S/Ps reported on WISP did not significantly differ between cancer and non-cancer patients, except for existential problems, dysphagia, myoclonus, speaking problems, sweats, and vomiting. Conclusion: The similarities and differences in the prevalence of the most common S/Ps reported on WISP confirm that WISP improves symptom assessment regardless of patient diagnosis.
- 26 September 2023
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 62 (12) , 1749-1756
Diagnosis and treatment of breast cancer in Denmark during the COVID-19 pandemic: a nationwide population-based study
The COVID-19 pandemic was a global health crisis with population-wide behavioural restrictions imposed worldwide to reduce transmission of infection and to limit the potential burden on the healthcare systems. We examined whether there was any change in the diagnosis or treatment of breast cancer during the pandemic as compared to previous years. The study population comprised all women aged ≥18 years diagnosed with breast cancer in 2015-2021 with data obtained from the clinical quality registry of the Danish Breast Cancer Cooperative Group (DBCG). Data on socioeconomic factors were retrieved from Statistics Denmark. Prevalence ratios (PR) with 95% confidence intervals (CI) were estimated from a generalised linear model (GLM) with a log link for the Poisson family with robust standard errors (SE) of each outcome, using the COVID-19 pandemic period in Denmark as the exposure of interest. In total, 30,598 breast cancers were diagnosed during the study period. There was a small decrease (4.5%) in the total number of breast cancer cases in 2020 compared with previous years. During the pandemic, a lower proportion of the patients diagnosed with breast cancer had a short educational level (28.5 vs. 26.9%; PR = 0.91; 95% CI: 0.88-0.95), a low income (20.5 vs. 19.0%; PR = 0.90; 0.85-0.95) and fewer than expected in the age group 60-69 years (27.8 vs. 25.3; PR = 0.90; 0.86-0.94) were diagnosed, as compared with the pre-pandemic period. No difference in type of surgery or tumour size was observed. A higher proportion of patients received neo-adjuvant chemotherapy (49.0 vs 55.0%; PR = 1.15; 1.06-1.24), whereas a lower proportion received adjuvant chemotherapy (93.5 vs 85.6%; PR = 0.92; 0.90-0.93) during the pandemic, compared with the pre-pandemic period. During the pandemic, a small decrease in the number of breast cancer diagnoses was observed particularly among socially disadvantaged groups. Overall, the quality of breast cancer treatment was maintained.
- 26 September 2023
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 62 (12) , 1749-1756
Diagnosis and treatment of breast cancer in Denmark during the COVID-19 pandemic: a nationwide population-based study
The COVID-19 pandemic was a global health crisis with population-wide behavioural restrictions imposed worldwide to reduce transmission of infection and to limit the potential burden on the healthcare systems. We examined whether there was any change in the diagnosis or treatment of breast cancer during the pandemic as compared to previous years. The study population comprised all women aged ≥18 years diagnosed with breast cancer in 2015-2021 with data obtained from the clinical quality registry of the Danish Breast Cancer Cooperative Group (DBCG). Data on socioeconomic factors were retrieved from Statistics Denmark. Prevalence ratios (PR) with 95% confidence intervals (CI) were estimated from a generalised linear model (GLM) with a log link for the Poisson family with robust standard errors (SE) of each outcome, using the COVID-19 pandemic period in Denmark as the exposure of interest. In total, 30,598 breast cancers were diagnosed during the study period. There was a small decrease (4.5%) in the total number of breast cancer cases in 2020 compared with previous years. During the pandemic, a lower proportion of the patients diagnosed with breast cancer had a short educational level (28.5 vs. 26.9%; PR = 0.91; 95% CI: 0.88-0.95), a low income (20.5 vs. 19.0%; PR = 0.90; 0.85-0.95) and fewer than expected in the age group 60-69 years (27.8 vs. 25.3; PR = 0.90; 0.86-0.94) were diagnosed, as compared with the pre-pandemic period. No difference in type of surgery or tumour size was observed. A higher proportion of patients received neo-adjuvant chemotherapy (49.0 vs 55.0%; PR = 1.15; 1.06-1.24), whereas a lower proportion received adjuvant chemotherapy (93.5 vs 85.6%; PR = 0.92; 0.90-0.93) during the pandemic, compared with the pre-pandemic period. During the pandemic, a small decrease in the number of breast cancer diagnoses was observed particularly among socially disadvantaged groups. Overall, the quality of breast cancer treatment was maintained.